204 related articles for article (PubMed ID: 34858841)
1. Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study.
Pozzuto L; Silveira MN; Mendes MCS; Macedo LT; Costa FO; Martinez CAR; Coy CSR; da Cunha Júnior AD; Carvalheira JBC
Front Oncol; 2021; 11():762444. PubMed ID: 34858841
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
3. Influence of skeletal muscle and intermuscular fat on postoperative complications and long-term survival in rectal cancer patients.
Nie T; Wu F; Heng Y; Cai W; Liu Z; Qin L; Cao Y; Zheng C
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):702-717. PubMed ID: 38293722
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography-measured body composition parameters do not influence survival in non-metastatic colorectal cancer.
Cárcamo L; Peñailillo E; Bellolio F; Miguieles R; Urrejola G; Zúñiga A; Molina ME; Larach JT
ANZ J Surg; 2021 May; 91(5):E298-E306. PubMed ID: 33682291
[TBL] [Abstract][Full Text] [Related]
5. Varying clinical relevance of sarcopenia and myosteatosis according to age among patients with postoperative colorectal cancer.
Cho HJ; Lee HS; Kang J
J Nutr Health Aging; 2024 Apr; 28(7):100243. PubMed ID: 38643603
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
8. Myosteatosis in a systemic inflammation-dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer.
Gabiatti CTB; Martins MCL; Miyazaki DL; Silva LP; Lascala F; Macedo LT; Mendes MCS; Carvalheira JBC
Cancer Med; 2019 Nov; 8(16):6967-6976. PubMed ID: 31571402
[TBL] [Abstract][Full Text] [Related]
9. Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality.
Engelmann SU; Pickl C; Haas M; Kaelble S; Hartmann V; Firsching M; Lehmann L; Gužvić M; van Rhijn BWG; Breyer J; Burger M; Mayr R
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980664
[TBL] [Abstract][Full Text] [Related]
10. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
11. Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis.
Lee CM; Kang J
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1270-1282. PubMed ID: 32483936
[TBL] [Abstract][Full Text] [Related]
12. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
13. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
Aro R; Mäkäräinen-Uhlbäck E; Ämmälä N; Rautio T; Ohtonen P; Saarnio J; Meriläinen S
Eur J Surg Oncol; 2020 Sep; 46(9):1656-1662. PubMed ID: 32224072
[TBL] [Abstract][Full Text] [Related]
14. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
[TBL] [Abstract][Full Text] [Related]
16. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer.
Kim Y; Lee JH; Cho ES; Lee HS; Shin SJ; Park EJ; Baik SH; Lee KY; Kang J
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):860-868. PubMed ID: 36696881
[TBL] [Abstract][Full Text] [Related]
17. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
[TBL] [Abstract][Full Text] [Related]
18. CT-based assessment of body composition and skeletal muscle in melanoma: A systematic review.
Youn S; Jogiat U; Baracos VE; McCall M; Eurich DT; Sawyer MB
Clin Nutr ESPEN; 2021 Oct; 45():127-133. PubMed ID: 34620308
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
[TBL] [Abstract][Full Text] [Related]
20. Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer.
Kusunoki Y; Okugawa Y; Toiyama Y; Kusunoki K; Ichikawa T; Ide S; Shimura T; Kitajima T; Imaoka H; Fujikawa H; Yasuda H; Yokoe T; Okita Y; Mochiki I; Ohi M; McMillan DC; Nakatani K; Kusunoki M
Clin Nutr; 2021 May; 40(5):2640-2653. PubMed ID: 33933730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
